Healthequity Inc (NASDAQ:HQY) VP Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction dated Wednesday, February 20th. The shares were sold at an average price of $77.87, for a total transaction of $311,480.00. Following the transaction, the vice president now owns 74,000 shares in the company, valued at $5,762,380. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.
NASDAQ:HQY traded down $0.64 on Thursday, reaching $79.37. The stock had a trading volume of 1,274,417 shares, compared to its average volume of 947,106. The firm has a market cap of $4.99 billion, a price-to-earnings ratio of 146.98, a price-to-earnings-growth ratio of 2.61 and a beta of 1.64. Healthequity Inc has a 12-month low of $47.33 and a 12-month high of $101.58.
Get Healthequity alerts:Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, December 4th. The company reported $0.22 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.20 by $0.02. The business had revenue of $70.50 million for the quarter, compared to analyst estimates of $69.60 million. Healthequity had a net margin of 24.52% and a return on equity of 12.42%. The company’s revenue was up 24.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.17 EPS. As a group, equities analysts predict that Healthequity Inc will post 0.91 earnings per share for the current year.
A number of brokerages have commented on HQY. Zacks Investment Research downgraded shares of Healthequity from a “hold” rating to a “sell” rating in a research note on Thursday. ValuEngine lowered shares of Healthequity from a “buy” rating to a “hold” rating in a research note on Saturday, December 15th. BidaskClub upgraded shares of Healthequity from a “hold” rating to a “buy” rating in a research report on Wednesday. Chardan Capital restated a “buy” rating and set a $78.00 price target (down previously from $82.00) on shares of Healthequity in a research report on Thursday, February 7th. Finally, Cantor Fitzgerald increased their price objective on shares of Healthequity from $80.00 to $83.00 and gave the company an “overweight” rating in a report on Thursday, February 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating and twelve have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $89.62.
A number of large investors have recently modified their holdings of the business. Legacy Financial Advisors Inc. acquired a new stake in shares of Healthequity during the fourth quarter worth approximately $28,000. MERIAN GLOBAL INVESTORS UK Ltd bought a new stake in shares of Healthequity during the fourth quarter valued at about $28,000. Duncker Streett & Co. Inc. acquired a new position in Healthequity during the fourth quarter worth about $30,000. Ffcm LLC purchased a new position in Healthequity in the 4th quarter worth about $122,000. Finally, Advisors Asset Management Inc. increased its stake in Healthequity by 57.4% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,136 shares of the company’s stock worth $160,000 after purchasing an additional 779 shares in the last quarter. 91.44% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This news story was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/4169641/insider-selling-healthequity-inc-hqy-vp-sells-4000-shares-of-stock.html.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Story: Asset Allocation Models, Which is Right For You?
No comments:
Post a Comment